The identified DEGs, which were involved in cell cycle, including CDC20, BUB1, GLIPR1, MCM2, and CCNB1, could have a crucial function in the development of breast cancer, and may become potential targets or prognostic markers for breast cancer. Here, CDC20 is linked to breast carcinoma.